Reduced motivation in the BACHD rat model of huntington disease is dependent on the choice of food deprivation strategy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Jansson, Erik Karl Håkan ^a   Clemens, Laura Emily ^a   Riess, Olaf ^a   Nguyen, Huu Phuc ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FOOD DEPRIVATION; FOOD INTAKE; GENOTYPE; HUNGER; HUNTINGTON CHOREA; MALE; MOTIVATION; NONHUMAN; OBESITY; PHENOTYPE; RAT; REWARD; WILD TYPE; ANIMAL; DISEASE MODEL; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; DISEASE MODELS, ANIMAL; FOOD DEPRIVATION; HUNTINGTON DISEASE; MALE; MOTIVATION; MOTOR ACTIVITY; RATS;

EID: 84938613133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105662     Document Type: Article

References (55)

1. Pringsheim T, Wiltshire K, Day L, Dykesman J, Steeves T, et al. (2012) The incidence and prevalence of huntington's disease: a systematic review and metaanalysis. Mov Disord 9: 1083-1091.
2. The Huntington's disease collaborative research group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington's disease chromosomes. Cell 72: 971-983.
3. Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanism and potential therapeutocal targets in huntington's disease. Physiol Rev 90: 905-981.
4. Djoussé L, Knowlton B, Cupples LA, Marder K, Shoulson I, et al. (2002) Weight loss in early stage of huntington's disease. Neurology 59: 1325-1330. (Pubitemid 35285981)
5. Kirkwood SC, Su JL, Conneally M, Foround T (2001) Progression of symptoms in the early and middle stages of huntington disease. Arch Neurol 58: 273-278. (Pubitemid 32163165)
6. Aziz NA, van der Burg JMM, Landwehrmeyer GB, Brundin P, Stinjen T, et al. (2008) Weight loss in huntington disease increases with higher CAG repeat number. Neurology 71: 1506-1513.
7. Robbins AO, Ho AK, Barker RA (2006) Weight changes in huntington's disease. Eur J Neurol 13: e7.
8. van der Burg JMM, Björkqvist M, Brundin P (2009) Beyond the brain: widespread pathology in huntington's disease. Lancet Neurol 8: 765-774.
9. Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MGM, Bloem BR, et al. (2008) Weight loss in neurodegenerative disorders. J Neurol 255: 1872-1880.
10. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, et al. (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28: 6182-6195.
11. van Raamsdonk JM, Metzler M, Slow E, Pearson J, Schwab C, et al. (2007) Pheontypic abnormalities in the YAC128 mouse model of huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol Dis 26: 189-200. (Pubitemid 46436497)
12. Kudwa AE, Menalled LB, Oakeshott S, Murphy C, Mushlin R, et al. (2013) Increased body weight of the BAC HD transgenic mouse model of huntington's disease accounts for some but not all of the observed HD-like motor deficits. PLoS Curr 30: 5. Available: http://currents.plos.org/hd/article/increased-body- weight-of-the-bac-hd-transgenic-mouse-model-of-huntingtons-disease-accounts-for- some-but-not-all-of-the-observed-hd-like-motor-deficits/. Accessed 12 January 2014.
13. McFadyen MP, Kusek G, Bolivar VJ, Flaherty L (2003) Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod. Genes Brain Behav 2: 214-219. (Pubitemid 37010665)
14. Trueman RC, Dunnett SB, Brooks SP (2012) Operant-based instrumental learning for analysis of genetically modified models of huntington's disease. Brain Res Bull 88: 261-275.
15. Youn J, Ellenbroek BA, van Eck I, Roubos S, Verhage M, et al. (2011) Finding the right motivation: Genotype-dependent differences in effective reinforcements for spatial learning. Behav Brain Res226: 397-403.
16. Oakeshott S, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, et al. (2012) A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z-Q175 KI mouse models of Huntington's disease. PLoS Curr 25: 4. Available: http://currents.plos.org/hd/article/a-mixed-fixed- ratioprogressive-ratio-procedure-reveals-an-apathy-phenotype-in-the-bac-hd-and- the-z-q175-ki-mouse-models-of-huntingtons-disease/. Accessed 13 June 2012.
17. Oakeshott S, Farrar A, Port R, Cummins-Sutphen J, Berger J, et al. (2013) Deficits in a simple visual Go/No-go discrimination task in two mouse models of huntington's disease. PLoS Curr 7: 5. Available: http://currents.plos.org/hd/ article/deficits-in-a-simple-visual-gono-go-discrimination-task-in-two-mouse- models-of-huntingtons-disease/. Accessed 12 January 2014.
18. Enkel T, Berger SM, Schönig K, Tews B, Bartsch D (2014) Reduced expression of Nogo-A leads to motivational deficits in rats. Front Behav Neurosci 8: 10. Available: http://journal.frontiersin.org/Journal/10.3389/fnbeh. 2014.00010/full. Accessed 7 March 2014.
19. Bradbury MJ, Campbell U, Giracello D, Chapman D, King C, et al. (2005) Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. J Pharmacol Exp Ther 313: 395-402. (Pubitemid 40411366)
20. Roth JD, D'Souza L, Griffin PS, Athanacio J, Trevaskis JL, et al. (2012) Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents. Diabetes Obes Metab 14: 608-615.
21. Fielding SA, Brooks SP, Klein A, Bayram-Weston Z, Jones J, et al. (2012) Profiles of motor and cognitive impairment in the transgenic rat model of huntingtin's disease. Brain Res Bull 88: 223-236.
22. Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, et al. (2012) A novel BACHD transgenic rat exhibits characteristic neuropathological features of huntington disease. J Neurosci 32: 15426-15438.
23. Abada YK, Nguyen HP, Ellenbroek B, Schreiber R (2013) Reversal learning and associative memory impairments in a BACHD rat model for huntington disease. PLoS One 8: 10. Available: http://www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0071633. Accessed 24 November 2013.
24. Clemens LE, Jansson EKH, Portal E, Riess O, Nguyen HP (2014) A behavioral comparison of the common laboratory rat strains lister hooded, lewis, fischer 344 and wistar in an automated homecage system. Genes Brain Behav 13: 305-21.
25. She P, Zhang Z, Marchionini D, Diaz WC, Jetton T, et al. (2011) Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of huntington's disease. Am J Physiol Endocrinol Metab 301: E49-E61.
26. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, et al. (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8: 397-407. (Pubitemid 29097327)
27. von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, et al. (2003) Transgenic rat model of huntington's disease. Hum Mol Genet 12: 617-624. (Pubitemid 36372488)
28. Hult S, Soylu R, Björklund T, Belgardt BF, Mauer J, et al. (2011) Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. Cell Metab 13: 428-439.
29. van Raamsdonk JM, Gibson WT, Pearson J, Murphy Z, Lu G, et al. (2006) Body weight is modulated by levels of full-length huntingtin. Hum Mol Genet 15: 1513-1523.
30. Weydt P, Pineda W, Torrence AE, Libby RT, Satterfield TF, et al. (2006) Thermoregulatory and metabolic dfects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 4: 349-362. (Pubitemid 44645069)
31. Hollopeter G, Erickson JC, Palmiter RD (1998) Role of neuropeptide Y in diet-, chemical and genetic-induced obesity of mice. Int J Obes Relat Metab Disord 22: 506-512. (Pubitemid 28254480)
32. Tanaka K, Shimada M, Nakao K, Kusunoki T (1978) Hypothalamic lesion induced by injection of monosodium glutamate in suckling period and subsequent development of obesity. Exp Neurol 62: 191-199. (Pubitemid 9037526)
33. Morris MJ, Tortelli CF, Filippis A, Proietto J (1998) Reduced BAT as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. Regul Pept 25: 441-447. (Pubitemid 28477558)
34. Chen W, Chen Z, Xue N, Zheng Z, Li S, et al. (2013) Effect of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats. Naunyn Schmiedebergs Arch Pharmacol 8: 721-732.
35. Scallet AC and Olney JW (1986) Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia. Brain Res (2): 380-384. (Pubitemid 16077991)
36. Bergen HT, Mizuno TM, Taylor J, Mobbs CV (1998) Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin. Endocrinology 139: 4483-4488. (Pubitemid 28487763)
37. Remmers F, Fodor M, Delemarre-van de Waal H (2008) Neonatal food restriction permanently alters rat body dimensions and energy intake. Physiol Behav 95: 208-215.
38. Nguyen GD, Molero AE, Gokhan S, Mehler MF (2013) Functions of huntingtin in germ layer specification and organogenesis. PLoS One 8: 8. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072698. Accessed 11 March 2014.
39. Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, et al. (2012) Measures of growth in children at risk for Huntington disease. Neurology 79: 668-674.
40. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, et al. (1996) Executive and mnemotic functions in early huntington's disease. Brain 119: 1633-1645. (Pubitemid 26375733)
41. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R (2004) Cognitive changes in patients with huntington's disease (HD) and asymptomatic carriers of the HD mutation a longitudinal follow-up study. J Neurol 251: 935-942. (Pubitemid 39119311)
42. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS, et al. (2012) Cognitive domains that predict time to diagnosis in prodromal huntington disease. J Neurosurg Psychiatry 83: 612-619.
43. Meyer C, Landwehrmeyer B, Schwenke C, Doble A, Orth M, et al. (2012) Rate of change in early huntington's disease: a clinicometric analysis. Mov Disord 27:118-124.
44. Vaccarino AL, Anderson K, Borowsky B, Duff K, Giuliano J, et al. (2011) An item response analysis of the motor and behavioral subscales of the unified huntington's disease rating scale in huntington disease gene expansion carriers. Mov Disord 26: 877-884.
45. Whisaw IQ, Tompkins GJ (1988) An optic-fiber photocell detector for measuring tongue protrusion in the rat: evaluation of recovery from localized cortical lesions. Psychol Behav 43: 397-401.
46. Trueman RC, Brooks SP, Jones L, Dunnett SB (2009) Rule learning, visuospatial function and motor performance in the HdhQ92 knock-in mouse model of Huntington's disease. Behav Brain Res 203: 215-222.
47. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL (2001) Neuropsychiatric aspects of huntington's disease. J Neurol Neurosurg Psychiatry 71: 310-314. (Pubitemid 32772526)
48. Naarding P, Janzing JGE, Eling P, van der Werf S, Kremer B (2009) Apathy is not depression in huntington's disease. J Neuropsuchiatry Clin Neurosci 21: 266-270.
49. Skjoldager P, Pierre PJ, Mittleman G (1993) Reinforcer magnitude and progressive ratio responding in the rat: effect of increased effort, prefeeding, and extinction. Learning Motivation 24: 303-343.
50. Eagle DM, Humby T, Dunnett SB, Robbins TW (1999) Effects of regional striatal lesions on motor, motivational, and executive aspects of progressive-ratio performance in rats. Behav Neurosci 133: 718-731. (Pubitemid 29426691)
51. Schmelzeis MC, Mittleman G (1996) The hippocampus and reward: effects of hippocampal lesions on progressive-ratio responding. Behav Neurosci 110: 1049-1066. (Pubitemid 26365804)
52. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, et al. (1995) Weightreducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546.
53. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, et al. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci 94: 8878-8883. (Pubitemid 27335133)
54. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, et al. (1995) Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161.
55. Kanoski SE, Alhadeff AL, Fortin SM, Gilbert JR, Grill HJ (2014) Leptin signaling in the medial nucleus tractus solitarius reduced food seeking and willingness to work for food. Neuropsychopharmacology 39: 605-613.